We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ablation Could Alleviate Back Pain When Steroids Fail

By HospiMedica International staff writers
Posted on 12 Mar 2012
Patients with lower back pain who do not respond to intra-articular steroid injections may still be candidates for treatment with radiofrequency ablation (RFA), according to a new study. More...


Researchers at the Cleveland Clinic (OH, USA) conducted a retrospective study of 80 patients who underwent preoperative intraarticular steroid injections from January 2006 to June 2009. The researchers related that traditionally, the degree of pain relief from steroid injections has been used to determine if patients would be good candidates for RFA of the lateral branches that innervate the sacroiliac joint. In these cases, RFA of the lateral branches is often considered only if the patient had more than 50% pain reduction from the intraarticular steroid injection.

The researchers found that after adjusting for variables such as age, modes of pain onset, multiple pain complaints, and responses to extension or axial rotation of the lumbar spine in the multivariable proportional hazards model, the difference in duration of post-RFA pain relief between the groups was not significant, and was independent of the degree of pain relief within the range of 25%-100% after steroid injections. The study was presented at the American Academy of Pain Medicine annual meeting, held during February 2012 in Palm Springs (FL, USA).

“The duration of pain relief after radiofrequency ablation ... is independent of the degree of pain relief within the range of 25% to 100% after sacroiliac intraarticular steroid injections,” said lead author and study presenter Jianguo Cheng, MD, PhD. “Don't disqualify a patient from radiofrequency ablation if they only achieved 25% to 49% relief from steroid injections.”

The researchers noted that patients with the more robust responses to intraarticular steroid injections were older, were more likely to have pain radiating to the leg, more likely to have gradual onset pain, and were less likely to have pain with extension or axial rotation.

Related Links:
Cleveland Clinic




Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.